Biologics milestone as court denies declaratory judgment

13-11-2013

Biologics milestone as court denies declaratory judgment

The US District Court for the Northern District of California has dismissed biosimilar maker Sandoz’s motion for declaratory judgment that its etanercept product does not infringe biopharmaceutical company Amgen’s arthritis drug Enbrel.


Biologics Act, declaratory judgment, Amgen, Sandoz, Enbrel

LSIPR